MIOCHOL-E

This brand name is authorized in Canada, Estonia, Finland, Ireland, Malta, New Zealand, Singapore, South Africa, UK.

Active ingredients

The drug MIOCHOL-E contains one active pharmaceutical ingredient (API):

1	Acetylcholine UNII AF73293C2R - ACETYLCHOLINE CHLORIDE
	Acetylcholine is a physiological neuromediator of postganglionic parasympathetic nerve fibres (muscarinic action), skeletal muscles and ganglia of the sympathetic system (nicotinic action).
	Read more about Acetylcholine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MIOCHOL-E Powder and solvent for instillation solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01EB09	Acetylcholine	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EB Parasympathomimetics
Discover more medicines within S01EB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02133326
EE	Ravimiamet	1825343
FI	Lääkealan turvallisuus- ja kehittämiskeskus	019235
GB	Medicines & Healthcare Products Regulatory Agency	110557
MT	Medicines Authority	AA565/40501
NZ	Medicines and Medical Devices Safety Authority	10770
SG	Health Sciences Authority	09252P
ZA	Health Products Regulatory Authority	28/15.4/0506